Mother-to-child transmission of hepatitis C virus infection occurs in a significant minority of cases and the diagnosis, treatment and cure of hepatitis C virus infection with direct acting antivirals prior to pregnancy can eliminate this risk in almost all cases. Women with hepatitis C virus infection have increased risks of adverse events in pregnancy and poor perinatal outcomes for their children, although the contribution of hepatitis C virus per se is difficult to determine. Altering the mode of delivery does not reduce mother to child transmission of hepatitis C virus infection, although avoidance of fetal scalp electrodes and other potential high risk procedures is recommended during pregnancy and delivery. Breast feeding has not been demonstrated to be a risk for mother-to-child transmission and avoidance of breast feeding is not recommended, although breast feeding with cracked or bleeding nipples is generally avoided. Safety of the currently available hepatitis C virus antivirals in pregnancy and breastfeeding has not yet been established.
ThriftAPEl-SeragHBKanwalF. Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol2017; 14: 122–132.
2.
BadenRRockstrohJKButiM. Natural history and management of hepatitis C: does sex play a role?J Infect Dis2014209 Suppl 3): S81–S85.
3.
SelvapattNWardTBaileyHet al.Is antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre. J Hepatol2015; 63: 797–804.
4.
UrbanusATvan KeepMMatserAAet al.Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?PLoS One2013; 8: e70319–e70319.
5.
BotteroJBrouardCRoudot-ThoravalFet al.French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV. Liver Int2016; 36: 1442–1449.
6.
KopilovićBPoljakMSemeKet al.Hepatitis C virus infection among pregnant women in Slovenia: study on 31,849 samples obtained in four screening rounds during 1999, 2003, 2009 and 2013. Euro Surveill2015; 20: 21144–21144.
7.
WilsonEBeckmannM. Antenatal screening for hepatitis C: universal or risk factor based?Aust N Z J Obstet Gynaecol2015; 55: 318–322.
8.
WaruingiWMhannaMJKumarDet al.Hepatitis C Virus universal screening versus risk based selective screening during pregnancy. J Neonatal Perinatal Med2015; 8: 371–378.
9.
El-KamarySSHashemMSalehDAet al.Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt. J Infect2015; 70: 512–519.
10.
GervaisABacqYBernuauJet al.Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol2000; 32: 293–299.
11.
Ruiz-ExtremeraAMuñoz-GámezJAAbril-MolinaAet al.Variation of transaminases, HCV-RNA levels and Th1/Th2 cytokine production during the post-partum period in pregnant women with chronic hepatitis C. PLoS One2013; 8: e75613–e75613.
12.
ClohessyPPolisSPostJ. Spontaneous Clearance of Hepatitis C Virus during Pregnancy. Obstet Med2013; 6: 28–29.
13.
YangLZhaoRZhengYet al.Effect of hepatitis C virus infection on the outcomes of in vitro fertilization. Int J Clin Exp Med2015; 8: 6230–6235.
14.
PrisantNTubianaRLefebvreGet al.HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcome. Fertil Steril2010; 93: 1020–1023.
15.
WijarnpreechaKThongprayoonCSanguankeoAet al.Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol2017; 41: 39–45.
PergamSAWangCCGardellaCMet al.Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol2008; 199: 38.e1–e9.
18.
HuangQTHuangQZhongMet al.Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies. J Viral Hepat2015; 22: 1033–1042.
19.
GiuglianoSPetroffMGWarrenBDet al.Hepatitis C virus sensing by human trophoblasts induces innate immune responses and recruitment of maternal NK cells: potential implications for limiting vertical transmission. J Immunol2015; 195: 3737–3747.
20.
JabeenTCannonBHoganJet al.Pregnancy and pregnancy outcome in hepatitis C type 1b. QJM2000; 93: 597–601.
21.
SafirALevyASikulerEet al.Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int2010; 30: 765–770.
22.
BenovaLMohamoudYACalvertCet al.Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis2014; 59: 765–773.
23.
SnijdewindIJSmitCSchuttenMet al.Low mother-to-child-transmission rate of Hepatitis C virus in cART treated HIV-1 infected mothers. J Clin Virol2015; 68: 11–15.
24.
BaroncelliSPirilloMFAmiciRet al.HCV-HIV coinfected pregnant women: data from a multicentre study in Italy. Infection2016; 44: 235–242.
25.
Elrazek A, Amer M, Hawary B, et al. Prediction of HCV vertical transmission: what are factors should be optimized using data mining computational analysis. Liver Int 2017; 37: 529–533.
26.
Garcia-TejedorAMaiques-MontesinosVDiago-AlmelaVJet al.Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers. Eur J Obstet GynecolReprod Biol2015; 194: 173–177.
27.
DelotteJBarjoanEMBerrébiAet al.Obstetric management does not influence vertical transmission of HCV infection: results of the ALHICE group study. J Matern Fetal Neonatal Med2014; 27: 664–670.
28.
RestiMAzzariCGalliLet al.Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis2002; 185: 567–572.
29.
CottrellEBChouRWassonNet al.Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. preventive services task force. Ann Intern Med2013; 158: 109–113.
30.
BoxallEBaumannKPriceNet al.Discordant outcome of perinatal transmission of hepatitis C in twin pregnancies. J Clin Virol2007; 38: 91–95.
31.
KuncioDENewbernECJohnsonCCet al.Failure to test and identify perinatally infected children born to hepatitis C virus-infected women. Clin Infect Dis2016; 62: 980–985.
32.
MenonRMBadriPSWangTet al.Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir. J Hepatol2015; 63: 20–29.
BriggsGGFreemanRKTowersCVet al.Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, Philadelphia: Lippincott Williams & Wilkins, 2017.
35.
RobertsSSMillerRKJonesJKet al.The ribavirin pregnancy registry: findings after 5 years of enrollment, 2003-2009. Birth Def Res2010; 88: 551–559.
